Cancer research increasingly relies on sequencing and multi-omics technologies to investigate the molecular changes that contribute to tumour development, progression and treatment response.
From genomic variants and gene expression changes to epigenetic regulation, tumour heterogeneity and the tumour microenvironment, omics-based approaches can help researchers study cancer biology from multiple perspectives.
Novogene Europe supports cancer research projects with sequencing, single-cell, spatial, epigenomic and bioinformatics services designed to help generate reliable data for discovery, translational and precision oncology research.
Common Research Approaches
Identify genomic variants, copy-number changes and structural alterations that may contribute to cancer development, progression and tumour evolution.
Study gene expression patterns, fusion events and pathway-level changes across tumour samples, cell models and experimental treatment conditions.
Explore tumour heterogeneity, immune cell composition and tissue-level organisation within complex cancer samples and tumour microenvironments.
Investigate DNA methylation, chromatin-related changes and regulatory mechanisms involved in cancer biology and disease progression.
Novogene Europe provides access to a broad range of sequencing and omics technologies for cancer research, with project support from sample submission through to data delivery and analysis.
Depending on your research goals, our team can help identify suitable approaches across whole genome sequencing, exome sequencing, RNA sequencing, DNA methylation analysis, single-cell workflows, spatial omics and related bioinformatics options.
Cancer research increasingly relies on sequencing and multi-omics technologies to investigate the molecular changes that contribute to tumour development, progression and treatment response.
From genomic variants and gene expression changes to epigenetic regulation, tumour heterogeneity and the tumour microenvironment, omics-based approaches can help researchers study cancer biology from multiple perspectives.
Novogene Europe supports cancer research projects with sequencing, single-cell, spatial, epigenomic and bioinformatics services designed to help generate reliable data for discovery, translational and precision oncology research.
Common Research Approaches
Identify genomic variants, copy-number changes and structural alterations that may contribute to cancer development, progression and tumour evolution.
Study gene expression patterns, fusion events and pathway-level changes across tumour samples, cell models and experimental treatment conditions.
Explore tumour heterogeneity, immune cell composition and tissue-level organisation within complex cancer samples and tumour microenvironments.
Investigate DNA methylation, chromatin-related changes and regulatory mechanisms involved in cancer biology and disease progression.
Novogene Europe provides access to a broad range of sequencing and omics technologies for cancer research, with project support from sample submission through to data delivery and analysis.
Depending on your research goals, our team can help identify suitable approaches across whole genome sequencing, exome sequencing, RNA sequencing, DNA methylation analysis, single-cell workflows, spatial omics and related bioinformatics options.
